Ito M
Jpn Circ J. 1976 Nov;40(11):1285-300. doi: 10.1253/jcj.40.1285.
The effects of atropine on normal and anomalous A-V pathways were investigated using HBE in 40 cases consisting of 25 subjects without pre-excitation (group I) and 15 cases with WPW syndrome (group II). In group I, A-H interval shortened with a mean decrease of 30% following the administration of atropine (p less than 0.001), while P-A and H-V intervals as well as QRS duration remained unchanged. In group II the electrocardiogram showed WPW syndrome pattern (pattern W) in 12, normalization (pattern N) in 1 and both patterns (pattern WN) in 2 cases during the control study. In 10 cases pattern W persisted after atropine. Atropine changed pattern W to WN in 2 cases, WN to W in 1, WN to N in 1 and N to WN in one case. P-d interval remained constant. Atropine had no effect on the conduction time within atrium. His-Purkinje system and anomalous A-V pathway, but accelerated the transmission through A-V node. Atropine decreased the QRS duration of pattern W in 11 of 13 cases showing pattern W or WN both before and after atropine. Since the QRS duration showing pattern W correlated with P-H interval and (see article) and had the negative correlation with H-d interval (p less than 0.001), fusion mechanism was considered as the genesis of electrocardiographic pattern in most cases with WPW syndrome. Atropine influence was negative on QRS complex of pattern W i2 cases showing the co-existence of Kent bundle and James fibers or exclusive Kent bundle conduction. In the latter case the selection of antiarrhythmic agents should be made with caution. A-V dissociation with junctional rhythm developed in 9 cases (4 in group II) within 2 and a half minutes after atropine. The duration was as short as 15 seconds or less in 6 cases. The continuous tracing is necessary not to miss the AV dissociation. The disappearance of delta wave after atropine was observed during the change to pattern WN and the occurrence of A-V junctional rhythm or beat in 5 of 12 cases showing pattern W prior to the drug administration, and right bundle branch block was disclosed in 2 cases. The normalization of QRS complex also made it possible to measure His-Purkinje conduction time. In this point atropine is superior to the other antiarrhythmic agents which prolong H-V interval. Paroxysmal supraventricular tachycardia induced after atropine revealed shorter A-H with fixed H-V and V-A intervals, compared with the tachycardia before atropine in one case. The administration of atropine serves as an aid to evaluate the participation of anomalous A-V pathway in the tachycardia circuit.
采用希氏束电图(HBE)对40例患者进行研究,观察阿托品对正常和异常房室传导途径的影响。其中25例无预激综合征者为I组,15例WPW综合征患者为II组。I组中,静脉注射阿托品后,A-H间期缩短,平均缩短30%(P<0.001),而P-A、H-V间期及QRS波时限无改变。II组在对照研究时,12例心电图呈WPW综合征图形(W型),1例正常化(N型),2例呈两种图形(WN型)。静脉注射阿托品后,10例仍为W型,2例由W型转变为WN型,1例由WN型转变为W型,1例由WN型转变为N型,1例由N型转变为WN型。P-d间期无变化。阿托品对心房内、希氏-浦肯野系统及异常房室传导途径的传导时间无影响,但可加速房室结传导。13例注射阿托品前后呈W型或WN型的患者中,11例W型的QRS波时限缩短。由于呈W型的QRS波时限与P-H间期相关(见原文),与H-d间期呈负相关(P<0.001),故多数WPW综合征患者心电图图形的发生机制考虑为融合机制。12例呈W型且并存肯特束和詹姆斯纤维或仅有肯特束传导的患者中,2例注射阿托品后对W型QRS波群有负性影响。对后者,选择抗心律失常药物时应谨慎。9例(II组4例)在注射阿托品后2分半钟内出现房室分离伴交界性心律,6例持续时间短于15秒。需连续记录以免遗漏房室分离。12例用药前呈W型的患者中,5例在转变为WN型及出现房室交界性心律或心搏时,可见阿托品后δ波消失,2例出现右束支传导阻滞。QRS波群正常化后也可测量希氏-浦肯野系统传导时间。就此点而言,阿托品优于其他延长H-V间期的抗心律失常药物。1例患者注射阿托品后诱发的阵发性室上性心动过速,与用药前相比,A-H间期缩短,H-V及V-A间期固定。注射阿托品有助于判断异常房室传导途径是否参与心动过速环路。